Luna Innovations Incorporated Reports Third Quarter and First Nine Months of 2017 Financial Results
Net income from continuing operations improved to $0.5 million for the three months ended September 30, 2017
compared to a net loss from continuing operations of $(0.4) million for the three months ended September 30, 2016. Cash and
cash equivalents were $38.5 million at September 30, 2017.
Luna Innovations Incorporated (NASDAQ: LUNA) today announced its financial results for the three and nine months ended
September 30, 2017.
For the three months ended September 30, 2017, Luna reported net income of $15.8 million compared to a net loss of $(0.4)
million for the three months ended September 30, 2016. Net income for the 2017 period included an after-tax gain of $15.1 million
recognized on the sale of Luna's high speed optical receivers ("HSOR") business in August 2017. Net income from continuing
operations improved by $0.9 million, to $0.5 million, or $0.02 per share, for the three months ended September 30, 2017, compared
to a net loss from continuing operations of $(0.4) million, or $(0.01) per share, for the three months ended September 30, 2016.
Adjusted earnings before interest, taxes, depreciation and amortization ("Adjusted EBITDA") was $0.9 million for the three months
ended September 30, 2017 compared to $0.3 million for the three months ended September 30, 2016. A reconciliation of net
income/(loss) to adjusted EBITDA can be found in the schedules included in this release.
“We are extremely pleased with our third quarter financial results," said Scott Graeff, president and chief executive officer of
Luna. "The combination of positive income from our continuing operations for the quarter and the significant liquidity provided by
the sale of the HSOR business provides a solid foundation for Luna to continue to drive its fiber optic test & measurement
initiative. I am excited to be taking on the leadership of the company at this time of high growth potential within our strategic
initiative, supported by a highly dedicated group of talented employees and a strong balance sheet."
Third Quarter Financial Summary
Total revenues for the three months ended September 30, 2017, were $11.6 million compared to $11.2 million for the three
months ended September 30, 2016. Technology development revenues increased 11% to $4.6 million for the three months ended
September 30, 2017, compared to $4.1 million for the three months ended September 30, 2016. Products and licensing revenues
remained substantially unchanged at $7.1 million for the three months ended September 30, 2017 and 2016. The increase in the
technology development revenues for the three months ended September 30, 2017 compared to the three months ended September 30, 2016
was realized primarily in Luna's intelligent systems research group.
Gross profit was $4.5 million, or 39% of revenues, for the three months ended September 30, 2017, compared to gross profit
of $4.4 million, or 39% of revenues, for the three months ended September 30, 2016.
Selling, general and administrative expenses were $3.3 million for the three months ended September 30, 2017, compared to
$3.8 million for the three months ended September 30, 2016. The decrease in selling, general and administrative expense was
largely driven by a $0.2 million decrease in bad debt expense and a $0.2 million decrease in sales and marketing expenses resulting
from lower headcount in the three months ended September 30, 2017.
Research, development and engineering expenses remained substantially unchanged at $0.8 million for the three months ended
September 30, 2017 and 2016.
Net income from continuing operations improved to $0.5 million for the three months ended September 30, 2017, compared to a
net loss from continuing operations of $(0.4) million for the three months ended September 30, 2016. Net income from
discontinued operations was $15.2 million for the three months ended September 30, 2017, compared to a net loss from
discontinued operations of $(0.1) million for the three months ended September 30, 2016. Net income from discontinued
operations for the three months ended September 30, 2017, included the recognition of the after tax gain on the sale of the
HSOR business of $15.1 million in addition to after tax income of $0.1 million associated with the operations of the HSOR business
prior to its sale. Net loss from discontinued operations for the three months ended September 30, 2016, reflect the after tax
results of operations of the HSOR business during the period.
Net income attributable to common stockholders for the three months ended September 30, 2017 was $15.7 million, compared to a
net loss attributable to common stockholders of $(0.5) million for the three months ended September 30, 2016. Adjusted EBITDA was
$0.9 million for the three months ended September 30, 2017, compared to $0.3 million for the three months ended September 30,
2016.
Year to Date Financial Summary
Total revenues for the nine months ended September 30, 2017, were $33.0 million, compared to $30.1 million for the nine months
ended September 30, 2016. Technology development revenues increased 14% to $13.4 million for the nine months ended September 30,
2017, compared to $11.8 million for the nine months ended September 30, 2016. The increase in technology development revenues was
primarily as a result of increased sales in Luna's intelligent systems, nanomaterials, and biomedical technologies groups. Products
and licensing revenues were $19.6 million for the nine months ended September 30, 2017, compared to $18.3 million for the nine
months ended September 30, 2016. The increase in Products and Licensing segment revenues was primarily driven by an increase in
Luna's sales of optical backscatter reflectometer instruments and optoelectronic components.
Gross profit increased to $12.8 million, or 39% of revenues for the nine months ended September 30, 2017, compared to $11.1
million, or 37% of revenues, for the nine months ended September 30, 2016.
Selling, general and administrative expenses decreased to $10.3 million for the nine months ended September 30, 2017, compared
to $11.3 million for the nine months ended September 30, 2016. The decrease in selling, general and administrative expenses year to
date was primarily related to a $0.2 million decrease in bad debt expense, a $0.2 million decrease in share based compensation
expense, and a $0.4 million decrease in sales and marketing costs.
Research, development and engineering expenses decreased to $2.6 million for the nine months ended September 30, 2017, compared
to $2.8 million for the nine months ended September 30, 2016. The decrease was due to lower engineering costs in internal research
for Luna's Terahertz product as more engineering time was spent on externally funded research activities and, accordingly, included
in Luna's technology development cost of revenues.
Net loss from continuing operations improved to $(0.3) million for the nine months ended September 30, 2017, compared to $(3.0)
million for the nine months ended September 30, 2016. Net income from discontinued operations was $14.5 million for the nine months
ended September 30, 2017, compared to $0.3 million for the nine months ended September 30, 2016. Net income from discontinued
operations for the nine months ended September 30, 2017, included an after tax gain of $15.1 million recognized on the sale of the
HSOR business offset by an after tax loss of $(0.6) million related to the operations of the HSOR business prior to its sale. Net
income from discontinued operations for the nine months ended September 30, 2016, included the after tax income related to the
operations of the HSOR business during the period.
Net income/(loss) attributable to common stockholders improved to a net income of $14.1 million for the nine months ended
September 30, 2017, compared to a net loss of $(2.8) million for the nine months ended September 30, 2016. Adjusted EBITDA
increased to $1.2 million for the nine months ended September 30, 2017, compared to $(1.2) million for the nine months ended
September 30, 2016.
Non-GAAP Measures
In evaluating the operating performance of its business, Luna’s management considers Adjusted EBITDA, which excludes certain
charges and credits that are required by generally accepted accounting principles (“GAAP”). Adjusted EBITDA provides useful
information to both management and investors by excluding the effect of certain non-cash expenses and items that Luna believes may
not be indicative of its operating performance, because either they are unusual and Luna does not expect them to recur in the
ordinary course of its business or they are unrelated to the ongoing operation of the business in the ordinary course. Adjusted
EBITDA should be considered in addition to results prepared in accordance with GAAP, but should not be considered a substitute for,
or superior to, GAAP results. Adjusted EBITDA has been reconciled to the nearest GAAP measure in the table following the financial
statements attached to this press release.
Conference Call Information
As previously announced, Luna will conduct an investor conference call at 5:00 pm (EST) today to discuss its financial results
for the three and nine months ended September 30, 2017, and recent business developments. The call can be accessed by dialing
844.578.9643 domestically or 270.823.1522 internationally prior to the start of the call. The participant access code is 2469766.
Investors are advised to dial in at least five minutes prior to the call to register. The conference call will also be webcast live
over the Internet. The webcast can be accessed by logging on to the “Investor Relations” section of the Luna website, www.lunainc.com , prior to the event. The webcast will be archived under the
“Webcasts and Presentations” section of the Luna website for at least 30 days following the conference call.
About Luna
Luna Innovations Incorporated (www.lunainc.com) is a leader in optical technology, providing unique capabilities in high speed optoelectronics
and high performance fiber optic test products for the telecommunications industry and distributed fiber optic sensing for the
aerospace and automotive industries. Luna is organized into two business segments, which work closely together to turn ideas into
products: a Technology Development segment and a Products and Licensing segment. Luna's business model is designed to accelerate
the process of bringing new and innovative technologies to market.
Forward-Looking Statements
The statements in this release that are not historical facts constitute “forward-looking statements” made pursuant to the safe
harbor provision of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. These statements
include Luna's expectations regarding the high growth potential within Luna's strategic initiative. Management cautions the reader
that these forward-looking statements are only predictions and are subject to a number of both known and unknown risks and
uncertainties, and actual results, performance, and/or achievements of Luna may differ materially from the future results,
performance, and/or achievements expressed or implied by these forward-looking statements as a result of a number of factors. These
factors include, without limitation, failure of demand for Luna's products and services to meet expectations, technological
challenges and those risks and uncertainties set forth in Luna’s periodic reports and other filings with the Securities and
Exchange Commission ("SEC"). Such filings are available on the SEC’s website at www.sec.gov and on Luna’s website at www.lunainc.com. The statements made in this release are based on information available to Luna as of the date
of this release and Luna undertakes no obligation to update any of the forward-looking statements after the date of this
release.
| |
| Luna Innovations Incorporated |
| Consolidated Statements of Operations |
|
|
|
|
|
|
|
Three Months Ended |
|
Nine Months Ended |
|
|
September 30, |
|
September 30, |
|
|
2017 |
|
2016 |
|
2017 |
|
2016 |
|
|
(unaudited) |
|
(unaudited) |
| Revenues: |
|
|
|
|
|
|
|
|
| Technology development |
|
$ |
4,590,054 |
|
|
$ |
4,118,245 |
|
|
$ |
13,428,428 |
|
|
$ |
11,772,731 |
|
| Products and licensing |
|
7,052,094 |
|
|
7,066,908 |
|
|
19,593,648 |
|
|
18,301,631 |
|
| Total revenues |
|
11,642,148 |
|
|
11,185,153 |
|
|
33,022,076 |
|
|
30,074,362 |
|
| Cost of revenues: |
|
|
|
|
|
|
|
|
| Technology development |
|
3,491,840 |
|
|
3,068,360 |
|
|
10,045,261 |
|
|
8,986,312 |
|
| Products and licensing |
|
3,617,547 |
|
|
3,758,765 |
|
|
10,201,459 |
|
|
9,954,987 |
|
| Total cost of revenues |
|
7,109,387 |
|
|
6,827,125 |
|
|
20,246,720 |
|
|
18,941,299 |
|
| Gross profit |
|
4,532,761 |
|
|
4,358,028 |
|
|
12,775,356 |
|
|
11,133,063 |
|
| Operating expense: |
|
|
|
|
|
|
|
|
| Selling, general and administrative |
|
3,256,074 |
|
|
3,816,679 |
|
|
10,345,964 |
|
|
11,296,389 |
|
| Research, development and engineering |
|
833,811 |
|
|
812,050 |
|
|
2,581,473 |
|
|
2,789,801 |
|
| Total operating expense |
|
4,089,885 |
|
|
4,628,729 |
|
|
12,927,437 |
|
|
14,086,190 |
|
| Operating income/(loss) |
|
442,876 |
|
|
(270,701 |
) |
|
(152,081 |
) |
|
(2,953,127 |
) |
| Other income (expense): |
|
|
|
|
|
|
|
|
| Other expense |
|
(3,389 |
) |
|
(231 |
) |
|
(4,258 |
) |
|
(1,904 |
) |
| Interest expense |
|
(55,099 |
) |
|
(71,991 |
) |
|
(179,860 |
) |
|
(237,081 |
) |
| Total other expense |
|
(58,488 |
) |
|
(72,222 |
) |
|
(184,118 |
) |
|
(238,985 |
) |
| Income/(loss) from continuing operations before income taxes |
|
384,388 |
|
|
(342,923 |
) |
|
(336,199 |
) |
|
(3,192,112 |
) |
| Income tax (benefit)/expense |
|
(130,977 |
) |
|
44,797 |
|
|
(63,350 |
) |
|
(173,801 |
) |
| Net income/(loss) from continuing operations |
|
515,365 |
|
|
(387,720 |
) |
|
(272,849 |
) |
|
(3,018,311 |
) |
| Gain on sale, net of $1,508,373 of related income taxes |
|
15,096,666 |
|
|
— |
|
|
15,096,666 |
|
|
— |
|
|
Income/(loss) from discontinued operations, net of income tax (benefit)/expense of $(349,515),
$(35,095), $(349,515), and $209,678.
|
|
145,293 |
|
|
(57,358 |
) |
|
(644,241 |
) |
|
342,685 |
|
| Net income/(loss) from discontinued operations |
|
15,241,959 |
|
|
(57,358 |
) |
|
14,452,425 |
|
|
342,685 |
|
| Net income/(loss) |
|
15,757,324 |
|
|
(445,078 |
) |
|
14,179,576 |
|
|
(2,675,626 |
) |
| Preferred stock dividend |
|
33,699 |
|
|
28,941 |
|
|
97,331 |
|
|
74,731 |
|
| Net income/(loss) attributable to common stockholders |
|
$ |
15,723,625 |
|
|
$ |
(474,019 |
) |
|
$ |
14,082,245 |
|
|
$ |
(2,750,357 |
) |
| Net income/(loss) per share from continuing operations: |
|
|
|
|
|
|
|
|
| Basic |
|
$ |
0.02 |
|
|
$ |
(0.01 |
) |
|
$ |
(0.01 |
) |
|
$ |
(0.11 |
) |
| Diluted |
|
$ |
0.02 |
|
|
$ |
(0.01 |
) |
|
$ |
(0.01 |
) |
|
$ |
(0.11 |
) |
| Net income/(loss) per share from discontinued operations: |
|
|
|
|
|
|
|
|
| Basic |
|
$ |
0.55 |
|
|
$ |
0.00 |
|
|
$ |
0.52 |
|
|
$ |
0.01 |
|
| Diluted |
|
$ |
0.47 |
|
|
$ |
0.00 |
|
|
$ |
0.52 |
|
|
$ |
0.01 |
|
| Net income/(loss) per share attributable to common stockholders: |
|
|
|
|
|
|
|
|
| Basic |
|
$ |
0.57 |
|
|
$ |
(0.02 |
) |
|
$ |
0.51 |
|
|
$ |
(0.10 |
) |
| Diluted |
|
$ |
0.48 |
|
|
$ |
(0.02 |
) |
|
$ |
0.51 |
|
|
$ |
(0.10 |
) |
| Weighted average common shares and common equivalent shares outstanding: |
|
|
|
|
|
|
|
|
| Basic |
|
27,692,539 |
|
|
27,605,028 |
|
|
27,611,905 |
|
|
27,531,730 |
|
| Diluted |
|
32,714,389 |
|
|
27,605,028 |
|
|
27,611,905 |
|
|
27,531,730 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Luna Innovations Incorporated |
| Consolidated Balance Sheets |
|
|
|
|
|
|
|
September 30,
2017
|
|
December 31,
2016
|
|
|
(unaudited) |
|
|
| Assets |
|
|
|
|
| Current assets: |
|
|
|
|
| Cash and cash equivalents |
|
$ |
38,514,437 |
|
|
$ |
12,802,458 |
|
| Accounts receivable, net |
|
8,940,405 |
|
|
10,269,012 |
|
| Inventory |
|
7,300,035 |
|
|
6,848,835 |
|
| Prepaid expenses and other current assets |
|
924,196 |
|
|
1,375,659 |
|
| Current assets held for sale |
|
— |
|
|
5,801,629 |
|
| Total current assets |
|
55,679,073 |
|
|
37,097,593 |
|
| Property and equipment, net |
|
3,145,769 |
|
|
3,482,687 |
|
| Intangible assets, net |
|
3,264,285 |
|
|
3,367,217 |
|
| Goodwill |
|
502,000 |
|
|
502,000 |
|
| Long term receivable- sale of HSOR business |
|
4,000,000 |
|
|
— |
|
| Other assets |
|
18,024 |
|
|
38,194 |
|
| Non-current assets held for sale |
|
— |
|
|
10,509,282 |
|
| Total assets |
|
$ |
66,609,151 |
|
|
$ |
54,996,973 |
|
| Liabilities and stockholders’ equity |
|
|
|
|
| Liabilities: |
|
|
|
|
| Current liabilities: |
|
|
|
|
| Current portion of long-term debt obligations |
|
$ |
1,833,333 |
|
|
$ |
1,833,333 |
|
| Current portion of capital lease obligations |
|
49,070 |
|
|
52,128 |
|
| Accounts payable |
|
2,188,776 |
|
|
2,954,742 |
|
| Accrued liabilities |
|
9,586,554 |
|
|
7,913,544 |
|
| Deferred revenue |
|
897,023 |
|
|
837,906 |
|
| Current liabilities held for sale |
|
— |
|
|
2,376,703 |
|
| Total current liabilities |
|
14,554,756 |
|
|
15,968,356 |
|
| Long-term deferred rent |
|
1,221,170 |
|
|
1,319,402 |
|
| Long-term debt obligations |
|
1,057,263 |
|
|
2,420,032 |
|
| Long-term capital lease obligations |
|
79,246 |
|
|
114,940 |
|
| Non-current liabilities held for sale |
|
— |
|
|
84,555 |
|
| Total liabilities |
|
16,912,435 |
|
|
19,907,285 |
|
| Commitments and contingencies |
|
|
|
|
| Stockholders’ equity: |
|
|
|
|
| Preferred stock, par value $0.001, 1,321,514 shares authorized, issued and
outstanding at September 30, 2017 and December 31, 2016 |
|
1,322 |
|
|
1,322 |
|
| Common stock, par value $0.001, 100,000,000 shares authorized, 28,402,887 and
27,988,104 shares issued, 27,815,060 and 27,541,277 shares outstanding at September 30, 2017 and December 31, 2016 |
|
29,074 |
|
|
28,600 |
|
| Treasury stock at cost, 587,827 and 446,827 shares at September 30, 2017 and December
31, 2016 |
|
(746,007 |
) |
|
(517,987 |
) |
| Additional paid-in capital |
|
83,204,263 |
|
|
82,451,958 |
|
| Accumulated deficit |
|
(32,791,936 |
) |
|
(46,874,205 |
) |
| Total stockholders’ equity |
|
49,696,716 |
|
|
35,089,688 |
|
| Total liabilities and stockholders’ equity |
|
$ |
66,609,151 |
|
|
$ |
54,996,973 |
|
|
|
|
|
|
|
|
|
|
| |
| Luna Innovations Incorporated |
| Consolidated Statements of Cash Flows |
|
|
|
|
|
Nine Months Ended September 30, |
|
|
2017 |
|
2016 |
|
|
(unaudited) |
| Cash flows provided by/(used in) operating activities |
|
|
|
|
| Net income/(loss) |
|
$ |
14,179,576 |
|
|
$ |
(2,675,626 |
) |
| Adjustments to reconcile net income/(loss) to net cash used in operating
activities |
|
|
|
|
| Depreciation and amortization |
|
2,241,867 |
|
|
2,759,877 |
|
| Share-based compensation |
|
476,428 |
|
|
665,354 |
|
| Bad debt expense |
|
40,753 |
|
|
255,522 |
|
| Loss on disposal of fixed assets |
|
3,640 |
|
|
— |
|
| Gain on sale of discontinued operations |
|
(15,096,666 |
) |
|
|
| Change in assets and liabilities |
|
|
|
|
| Accounts receivable |
|
2,127,794 |
|
|
(1,197,885 |
) |
| Inventory |
|
(2,251,236 |
) |
|
964,443 |
|
| Other current assets |
|
380,858 |
|
|
(381,632 |
) |
| Accounts payable and accrued expenses |
|
(1,581,608 |
) |
|
(1,055,060 |
) |
| Deferred revenue |
|
59,980 |
|
|
(120,871 |
) |
| Net cash provided by/(used in) operating activities |
|
581,386 |
|
|
(785,878 |
) |
| Cash flows provided by/(used in) investing activities |
|
|
|
|
| Acquisition of property and equipment |
|
(893,698 |
) |
|
(1,433,260 |
) |
| Intangible property costs |
|
(392,485 |
) |
|
(317,287 |
) |
| Proceeds from sale of property and equipment |
|
3,000 |
|
|
— |
|
| Proceeds from sales of discontinued operations |
|
28,026,528 |
|
|
— |
|
| Net cash provided by/(used in) investing activities |
|
26,743,345 |
|
|
(1,750,547 |
) |
| Cash flows provided by/(used in) financing activities |
|
|
|
|
| Payments on capital lease obligations |
|
(38,752 |
) |
|
(44,404 |
) |
| Payments of debt obligations |
|
(1,375,000 |
) |
|
(1,375,000 |
) |
| Repurchase of common stock |
|
(228,020 |
) |
|
(325,060 |
) |
| Proceeds from the exercise of options |
|
29,020 |
|
|
— |
|
| Net cash used in financing activities |
|
(1,612,752 |
) |
|
(1,744,464 |
) |
| Net decrease in cash or cash equivalents |
|
25,711,979 |
|
|
(4,280,889 |
) |
| Cash and cash equivalents-beginning of period |
|
12,802,458 |
|
|
17,464,040 |
|
| Cash and cash equivalents-end of period |
|
$ |
38,514,437 |
|
|
$ |
13,183,151 |
|
|
|
|
|
|
|
|
|
|
| |
| Luna Innovations Incorporated |
| Reconciliation of Net Loss to EBITDA and Adjusted EBITDA |
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
September 30, |
|
|
September 30, |
|
|
2017 |
|
2016 |
|
|
2017 |
|
2016 |
|
|
(unaudited) |
|
|
(unaudited) |
| Net income/(loss) |
|
$ |
15,757,324 |
|
|
$ |
(445,078 |
) |
|
|
$ |
14,179,576 |
|
|
$ |
(2,675,626 |
) |
| Less income/(loss) from discontinued operations, net of income taxes |
|
15,241,959 |
|
|
(57,358 |
) |
|
|
14,452,425 |
|
|
342,685 |
|
| Net income/(loss) from continuing operations |
|
515,365 |
|
|
(387,720 |
) |
|
|
(272,849 |
) |
|
(3,018,311 |
) |
| Interest expense |
|
55,099 |
|
|
71,991 |
|
|
|
179,860 |
|
|
237,081 |
|
| Tax (benefit)/expense |
|
(130,977 |
) |
|
44,797 |
|
|
|
(63,350 |
) |
|
(173,801 |
) |
| Depreciation and amortization |
|
279,147 |
|
|
327,235 |
|
|
|
929,615 |
|
|
1,089,240 |
|
| EBITDA |
|
718,634 |
|
|
56,303 |
|
|
|
773,276 |
|
|
(1,865,791 |
) |
| Share-based compensation |
|
154,671 |
|
|
200,326 |
|
|
|
476,428 |
|
|
665,354 |
|
| Adjusted EBITDA |
|
$ |
873,305 |
|
|
$ |
256,629 |
|
|
|
$ |
1,249,704 |
|
|
$ |
(1,200,437 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investor Contact:
Luna Innovations Incorporated
Dale Messick, CFO, 1-540-769-8400
IR@lunainc.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20171113006226/en/